-
Recent Posts
Categories
- Anesthesiology
- Avandia
- Biomedical Engineering
- Cardiology
- Clinical Trials
- Clinics
- Consumer Products
- Counterfeit Products
- Critical Care Medicine
- Dentistry
- Dermatology
- Emergency Rooms
- Endocrinology
- Eye Care
- Family Practice
- FDA 2011
- FDA 2012
- FDA 2013
- FDA Label Change
- FDA Notice
- FDA Recall
- FDA Safety Communication
- FDA Warning
- Gastroenterology
- Healthcare Professionals
- Hematology
- Home Care
- Hospitals
- Infectious Disease
- Internal Medicine
- Laboratory
- multiple sclerosis (MS)
- Nephrology
- Neurology
- Nursing
- OBGYN
- Oncology
- Ophthalmology
- Orthopaedic Surgery
- Pain Management
- Patients
- Pediatrics
- Pharmacy
- Physical Medicine
- Psychiatry
- Pulmonology
- Radiology
- Rheumatology
- Risk Manager
- Surgery
- Uncategorized
Archives
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
Category Archives: Pulmonology
Giraffe and Panda T-Piece Masks Resuscitation Systems Class 1 Recall
GE Healthcare, LLC, Giraffe and Panda T-Piece Resuscitation Systems and Mask Resuscitation Systems: Class 1 Recall – Potential Reversal of Oxygen/Air AUDIENCE: Risk Managers, Pulmonology ISSUE: The oxygen and air wall inlet fittings and/or labels on the back panel of … Continue reading
Posted in FDA 2013, FDA Recall, Pulmonology, Risk Manager
Tagged Class 1 Recall, Class I Recall, FDA recall, GE Healthcare, Giraffe, Giraffe and Panda T-Piece Masks Resuscitation Systems Class 1 Recall, Masks, Panda, Pulmonology, Recall, Resuscitation Systems, Risk Managers, T-Piece
Comments Off
Revatio sildenafil Drug Safety Communication
Revatio (sildenafil): Drug Safety Communication – Recommendation Against Use in Children AUDIENCE: Pediatrics, Cardiology, Pulmonology ISSUE: FDA notified healthcare professionals and their medical care organizations that Revatio (sildenafil) should not be prescribed to children (ages 1 through 17) for pulmonary … Continue reading
Posted in Cardiology, FDA 2012, FDA Safety Communication, FDA Warning, Pediatrics, Pulmonology
Tagged Cardiology, drug risks, Drug Safety Communication, FDA warning, PAH, Pediatrics, pulmonary arterial hypertension, Pulmonology, Revatio, Revatio sildenafil Drug Safety Communication, safety label changes, Safety Labeling Changes, sildenafil
Comments Off
Alere Triage Diagnostic Tests Class I Recall
Alere Triage Diagnostic Tests (Multiple Tests): Class I Recall – Potential for Significantly Decreased Precision Including Triage CardioProfiler Panel, Triage Cardiac Panel, Triage Profiler SOB Panel, Triage BNP, and Triage D-dimer AUDIENCE: Laboratory, Cardiology, Pulmonology, Risk Manager ISSUE: FDA notified … Continue reading
Posted in Cardiology, FDA 2012, FDA Recall, Laboratory, Pulmonology, Risk Manager
Tagged Alere Triage Diagnostic Tests, Alere Triage Diagnostic Tests Class I Recall, Cardiology, Class 1 Recall, Class I Recall, FDA recall, Laboratory, Pulmonology, Recall, Risk Manager
Comments Off